Evidence map›Paper›PMID 33247667›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.

Swarnima Singh, Rakesh Kumar, Uday Kumar, Rekha Kumari

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. GLR in Colorectal Cancers: An Easily Accessible Prognostic Marker.International journal of general medicine · 2024
    Article
  11. Review
  12. Article
  13. In-Depth Analysis of theInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Swarnima SinghDepartment of Biochemistry, Netaji Subhas Medical College and Hospital, Patna, India.ORCID https://orcid.org/00
Rakesh KumarDepartment of Surgical Gastroenterology and Liver Transplant, Indira Gandhi Institute of Medical Sciences, Patna, India.
Uday KumarDepartment of Biochemistry, Netaji Subhas Medical College and Hospital, Patna, India.
Rekha KumariDepartment of Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna, India.
Indira Gandhi Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the diagnostic value, pre-operative serum thymidine kinase 1(TK1), CEA, CA 19-9 and CA 72-4 levels were measured in 106 patients with colorectal carcinoma (53 colon and 53 rectal carcinoma patients) and 53 healthy controls. Sandwich Elisa, biotin-labeled antibody kit was used for TK1, and other tumor markers were measured using electro-chemiluminescence. Serum TK1 levels were significantly higher in CRC than in healthy controls (p <0.05) and showed significant associations with tumor stage, histopathological grade, lymph node status and metastasis (p <0.01). TK1 showed the highest (0.824-0.862) area under receiver operating characteristics curve (AUC) in comparison to other markers, and the AUC of the panel of combination tests performed even better (0.935-0.952). Significant variation was observed between the single biomarker test and their combination (Z test, p <0.01) and the Hosmer-Lemeshow test showed an adequate model of calibration. The algorithm based on combination of TK1, CEA, CA19-9 and CA72-4 can improve the diagnostic efficiency in CRC patients.<br />.

Indexed as

AdultAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCA-19-9 AntigenCarcinoembryonic AntigenCase-Control StudiesColorectal NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisThymidine KinaseAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCA-19-9 AntigenCA-72-4 antigenCarcinoembryonic AntigenThymidine Kinasethymidine kinase 1CEAcolorectal cancerthymidine kinase 1Tumor markers

Identifiers

PMID33247667
PMCPMC8033132
OpenAlexW3108145687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.